Berberine-based Nutraceutical for Blood Sugar and Metabolism
Diaberine
+ Placebo Capsule
Metabolic Diseases
+ Nutritional and Metabolic Diseases
Treatment Study
Summary
Study start date: October 3, 2024
Actual date on which the first participant was enrolled.This study is designed to test how well a supplement called Diaberine, which contains berberine, helps control blood sugar levels and improve metabolism. It involves 80 individuals who will participate over a period of 24 weeks. The study aims to provide insights into how effective and tolerable this supplement is for managing blood sugar, which could benefit those dealing with related health issues. This research is important as it explores potential new ways to support people with blood sugar regulation challenges. Participants in the study will be randomly assigned to either receive the Diaberine supplement or a placebo, which is a harmless pill that does not contain the active ingredient. The study is triple-blind, meaning that neither the participants, the researchers, nor the data analysts will know who is receiving the actual supplement and who is receiving the placebo. This approach helps ensure unbiased results. Throughout the 24 weeks, various measures will be taken to assess how well the supplement is working and whether it is well-tolerated by the participants.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.80 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 70 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
50% chance of being blinded to the placebo group
Treatment Groups
Group I
ExperimentalGroup II
PlaceboStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location